EcoDrugPlus

Ensembl ID : ENSACLG00000000278
Gene Symbol: -
Cross references: -
175 Possible Orthologues:

Ensembl ID : ENSACLG00000000945
Gene Symbol: -
Cross references: -
173 Possible Orthologues:

Ensembl ID : ENSACLG00000011250
Gene Symbol: -
Cross references: -
170 Possible Orthologues:

Ensembl ID : ENSACLG00000011251
Gene Symbol: -
Cross references: -
172 Possible Orthologues:

Ensembl ID : ENSACLG00000027523
Gene Symbol: -
Cross references: -
169 Possible Orthologues:

Ensembl ID : ENSACLG00000001249
Gene Symbol: -
Cross references: -
169 Possible Orthologues:

Ensembl ID : ENSACLG00000003662
Gene Symbol: -
Cross references: -
115 Possible Orthologues:

Ensembl ID : ENSACLG00000005102
Gene Symbol: -
Cross references: -
162 Possible Orthologues:

Ensembl ID : ENSACLG00000008241
Gene Symbol: -
Cross references: -
128 Possible Orthologues:

Ensembl ID : ENSACLG00000019712
Gene Symbol: -
Cross references: -
148 Possible Orthologues:

Ensembl ID : ENSACLG00000019783
Gene Symbol: -
Cross references: -
146 Possible Orthologues:

Ensembl ID : ENSACLG00000020844
Gene Symbol: -
Cross references: -
135 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).